Exchange Bank’s Bristol-Myers Squibb BMY Stock Holding History

Exchange Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Hold	29,306	–	–	1.05%	31
2026 Q1	$1.78M	Hold	29,306	–	–	1.23%	24
2025 Q4	$1.58M	Hold	29,306	–	–	1.09%	26
2025 Q3	$1.32M	Sell	29,306 -319	-1%	-$14.9K	0.92%	30
2025 Q2	$1.37M	Sell	29,625 -250	-0.8%	-$12.3K	1.09%	27
2025 Q1	$1.82M	Hold	29,875	–	–	1.47%	19
2024 Q4	$1.69M	Buy	29,875 +30	+0.1%	+$1.68K	1.36%	23
2024 Q3	$1.54M	Hold	29,845	–	–	1.26%	24
2024 Q2	$1.24M	Sell	29,845 -972	-3%	-$43.5K	1.05%	32
2024 Q1	$1.67M	Sell	30,817 -296	-1%	-$15.1K	1.37%	20
2023 Q4	$1.6M	Sell	31,113 -508	-2%	-$26.7K	1.38%	20
2023 Q3	$1.84M	Sell	31,621 -400	-1%	-$24.5K	1.76%	14
2023 Q2	$2.05M	Buy	+32,021	New	+$2.15M	1.98%	10

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Exchange Bank's BMY Position: Q2 2026 in Review

Exchange Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 29,306 shares worth $1.69M. The position accounts for 1.05% of the portfolio, ranked #31.

Exchange Bank first reported a position in BMY in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.05M in Q2 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Exchange Bank held 29,306 shares of Bristol-Myers Squibb worth $1.69M as of Q2 2026.
Exchange Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 1.05% of Exchange Bank's portfolio in Q2 2026, its #31 holding.
Exchange Bank first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 13 quarters since.
Exchange Bank's Bristol-Myers Squibb position peaked at $2.05M in Q2 2023.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Exchange Bank's 13F filing for Q2 2026, filed 9 Jul 2026.